Women in STEM

My Daughter Was in the Mass Shooting at Brown, and I Wasn’t Trained for What to Do

PUBLISHED 12/16/2025 by

The text, from a fellow ER doctor and former Brown University faculty member, arrived at 4:27 p.m. on Saturday: “Active shooter near Brown engineering building? Is Hannah ok?” Within seconds, I looked on my phone for my daughter’s location—she was on campus in Friedman Hall. I texted her. It was real. There was an active shooter. She was hiding in a bathroom with her four best friends. For the next 24 hours, I lived every parent’s nightmare while learning hard lessons about a reality even I was not trained for.

As an emergency medicine physician with over 20 years of experience, I’ve operated from positions of information and authority in mass casualties before. This weekend, I had neither. I was simply a mother trying to keep my daughter safe from 150 miles away, armed only with a phone and whatever guidance I could piece together. I want to share what I learned, because on Saturday, thousands of students were in lockdown texting their anxious parents, and I realized how unprepared we are for this side of the experience.

What to Know About the CDC’s Baseless New Guidance on Autism

PUBLISHED 11/24/2025 by

The rewriting of a page on the CDC’s website to assert the false claim that vaccines may cause autism sparked a torrent of anger and anguish from doctors, scientists and parents who say Health and Human Services Secretary Robert F. Kennedy Jr. is wrecking the credibility of an agency they’ve long relied on for unbiased scientific evidence.

The revised CDC webpage will be used to support efforts to ditch most childhood vaccines, said Angela Rasmussen, a virologist at the University of Saskatchewan and co-editor-in-chief of the journal Vaccine. “It will be cited as evidence, even though it’s completely invented,” she said.

International Telehealth Provider ‘Women on Web’ Vows to Keep Abortion Pills Flowing to the U.S., No Matter What

PUBLISHED 11/17/2025 by

As Republicans push the FDA to restrict mifepristone, the international online abortion service Women on Web is reassuring Americans that they will continue to support access to abortion pills in all 50 states, no matter what. Women on Web has served over 130,000 people worldwide since 2005 and began serving the U.S. in July 2024.

Venny Ala-Siurua, executive director of Women on Web, was recently named to the Top 100 Canada’s Most Powerful Women by the Women’s Executive Network Academe. Ms. spoke with Ala-Siurua about how their service connects people with pills, how they’re removing medical gatekeeping, and how they’re defending abortion access against digital censorship.

“We’ve always focused on countries where there are high restrictions on abortion. Unfortunately, the situation in some of the states in the U.S. qualifies now. … Many pharmacies and providers have stepped up internationally to support the U.S. and found ways of dispensing and shipping medicines really, really fast. …

“We are receiving around 30 requests per day from people in the U.S., though that number can rise during major political moments—for example, when Trump was elected or took office. Our U.S. care seekers live primarily in states with abortion bans. Globally, we currently handle approximately 4,000 requests each month.”

This FDA Decision Could Transform Menopause Care

PUBLISHED 11/12/2025 by and

On Monday, Nov. 10, the U.S. Department of Health and Human Services announced that the Food and Drug Administration would eliminate the “boxed labeling” requirement for estrogen products.

The “black box warning,” as it’s commonly called, is part of the fallout from a press conference that occurred more than 20 years ago, announcing the findings of the Women’s Health Initiative (WHI). It’s also been the subject of a half-century-long push and pull with the federal government.

Make no mistake, this has been a longstanding demand—it’s neither new nor MAHA-driven. Doctors and scientists have made the case for its removal since the start to no avail, arguing the data from the WHI—the largest, most expensive, and only randomized placebo-controlled study of post-menopausal women—never supported putting it there in the first place.

The FDA’s reversal of the labeling requirement is a major win for evidence-based medicine. Now it’s up to us to responsibly inform women of their choices.

Rest in Power: Jane Goodall, the Gentle Disrupter Whose Research on Chimpanzees Redefined What It Meant to Be Human

PUBLISHED 10/7/2025 by

To the public, she was a world-renowned scientist and icon. To me, she was Jane—my inspiring mentor and friend.

Goodall spoke of animals as having emotions and cultures, and in the case of chimps, communities that were almost tribal. She also named the chimps she observed, an unheard-of practice at the time, garnering ridicule from scientists who had traditionally numbered their research subjects.

Goodall was persuasive, powerful and determined, and she often advised me not to succumb to people’s criticisms. Her path to groundbreaking discoveries did not involve stepping on people or elbowing competitors aside.

An Open Letter to Rep. Kat Cammack From a Medical Doctor: It’s Abortion Bans That Make Doctors Afraid to Act, Not ‘the Radical Left’

PUBLISHED 7/10/2025 by | UPDATED 8/5/2025 at 11:19 A.M. PT

No woman may escape the cruelty of the nebulous and varying restrictions on reproductive healthcare in the post-Roe world—as Rep. Kat Cammack (R-Fla.) discovered in May 2024 when faced with a life-threatening ectopic pregnancy shortly after Florida’s six-week abortion ban took effect. Concerned by the lack of clarity in the wording of the law on the limits of intervention in pregnant patients, doctors reportedly delayed administering intramuscular methotrexate to terminate the pregnancy, out of fear of prosecution.

I’m a doctor. In this chaotic landscape, where reproductive healthcare policy and medical reality appear woefully divorced, my colleagues and I don’t know what misstep could land us in senseless litigation or with felony charges.

Rep. Cammack, your voice and your story have power. I hope you use them to reintroduce nuance and common sense to the discussion on women’s lives. There are many of us who will extend a hand across the aisle and work together with you to right some of the senseless wrongs. 

Biotech CEOs to FDA: Don’t Let Politics Override Science on Abortion Pill

PUBLISHED 7/10/2025 by

Fifty-three biotechnology industry leaders and investors representing dozens of companies and organizations issued a letter late last month advising the U.S. Food and Drug Administration: Follow the science on mifepristone, not political ideology.

The Biotech CEO Sisterhood initiated the letter, with Grace Colón as lead author and dozens of senior biotechnology leaders signed on in support. “We are urging the agency and the department to continue to follow the science,” said Colón, who warned that political interference in drug regulation undermines both public trust and the FDA’s authority.

How Reshma Saujani Makes the Invisible Work of Motherhood Impossible to Ignore

PUBLISHED 7/1/2025 by | UPDATED 7/7/2025 at 12:25 P.M. PT

Most women are taught to make motherhood look effortless. Reshma Saujani wants you to see that we were never supposed to do it alone.

In a country that still treats caregiving as a personal responsibility rather than a public good, Saujani is changing the script. Not by asking for sympathy, but by exposing the architecture of the lie—and building something better in its place.

“I come from a long line of rule-breakers,” she told me. “My parents fled a dictator. They landed in Chicago with nothing. I grew up surrounded by refugees who were just trying to make it work. That kind of survival teaches you two things: one, that struggle is constant—and two, that silence is dangerous.”

She was a rule-breaker long before she was a movement-builder—always challenging authority, always in detention. “I’ve never been good at following the script,” she said. And that’s exactly what makes her effective.

Illinois Lawmakers Pursue Creative Path to Protect Mifepristone Access—Even if FDA Revokes Approval

PUBLISHED 6/10/2025 by

While antiabortion extremists work to eliminate mifepristone from the shelves—and the FDA faces mounting antiabortion political pressure to revoke its approval—Illinois lawmakers are fighting back with a legal firewall: a first-of-its-kind bill to keep abortion pills on the market, even if the Trump administration bans them.

The Illinois General Assembly has passed HB 3637, legislation allowing clinicians to prescribe drugs removed from the FDA’s approved list—as long as the World Health Organization still recommends them. Under the bill, Illinois clinicians could continue prescribing and dispensing the abortion medication mifepristone—even if the Trump administration rolls back the FDA’s longstanding approval of the medication. The legislation now awaits the signature of Illinois Governor J.D. Pritzker.